Sanofi Pharma Ltd. | Balance Sheet

Fiscal year is January-December. All values INR Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
2,644
4,688
5,715
5,610
7,299
Total Accounts Receivable
3,231
2,945
1,704
5,044
2,721
Inventories
3,493
4,885
4,925
5,029
4,368
Other Current Assets
104
110
93
70
44
Total Current Assets
9,471
12,628
12,437
15,753
14,432
Net Property, Plant & Equipment
3,886
4,740
5,795
5,874
5,707
Total Investments and Advances
13
29
30
104
86
Long-Term Note Receivable
230
289
1,706
56
4,055
Intangible Assets
4,462
3,842
3,239
2,654
2,286
Other Assets
386
748
839
971
1,204
Total Assets
18,733
22,602
24,406
25,833
28,123
ST Debt & Current Portion LT Debt
-
1
15
-
-
Accounts Payable
1,871
3,267
2,241
2,308
3,269
Income Tax Payable
137
416
574
340
393
Other Current Liabilities
2,346
2,874
3,339
2,373
2,348
Total Current Liabilities
4,354
6,558
6,170
5,021
6,010
Provision for Risks & Charges
253
321
288
548
465
Deferred Taxes
367
539
1,203
1,013
1,031
Other Liabilities
7
-
114
-
-
Total Liabilities
5,266
7,744
8,134
7,003
7,859
Common Equity (Total)
13,467
14,858
16,272
18,830
20,264
Total Shareholders' Equity
13,467
14,858
16,272
18,830
20,264
Total Equity
13,467
14,858
16,272
18,830
20,264
Liabilities & Shareholders' Equity
18,733
22,602
24,406
25,833
28,123

About Sanofi Pharma

View Profile
Address
Sanofi House
Mumbai Maharashtra 400072
India
Employees -
Website http://www.sanofiindialtd.com
Updated 09/14/2018
Sanofi India Ltd. engages in the manufacture and distribution of pharmaceutical drugs. The firm offers its products under the AllStar, Amaryl M, Amaryl M Forte, Amaryl MV, Apidra, Arava, Augeoz, Brodactam, Cardace, Cardace Protect, Cardace AM, Cardace Meto, Caspercid, Cetapin P, Cetapin XR, Cetapin V, Clexane, Daonil, Daonil M, Frisium, Insuman Rapid, Insuman Comb 25, Insuman Comb 50, Lantus, Lasilactone 50 Lasix, Metosan XR, M-Nem, Rejusite, Amaryl, Semi-Daonil, Targocid, Taxotere, Telsite, Telsite AM, Telsite AM H, Telsite H, Trental, Vogsite Md, and Zolineg brands. It also focuses on the following therapeutic areas: diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines.